Thiopurine methyltransferase alleles in British and Ghanaian populations

被引:206
作者
Ameyaw, MM
Collie-Duguid, ESR
Powrie, RH
Ofori-Adjei, D
McLeod, HL
机构
[1] Univ Aberdeen, Dept Med & Therapeut, Inst Med Sci, Aberdeen AB25 2ZD, Scotland
[2] Univ Ghana, Sch Med, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana
基金
英国惠康基金;
关键词
D O I
10.1093/hmg/8.2.367
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thiopurine methyltransferase (TPMT) catalyses the S-methylation of thiopurine drugs such as 6-mercaptopurine, 6-thioguanine and azathioprine, TPMT activity is inherited as an autosomal co-dominant trait, and several mutations in the TPMT gene have been identified which correlate with a low activity phenotype. Although ethnic differences in TPMT activity have been described, population frequency analysis of TPMT alleles has not been well defined in different ethnic groups. The frequency of four allelic variants of the TPMT gene, TPMT*2, TPMT*3A, TPMT*3B and TPMT*3C were compared in British Caucasian (n = 199) and Ghanaian (n = 217) populations using PCR-RFLP and allele-specific PCR-based assays. TPMT*3C was found in 14.8% of Ghanaians (31 heterozygotes, one homozygote). The TPMT*2, TPMT*3A and TPMT*3B alleles were not detected in any of the Ghanaian samples analysed. In contrast, 10.1% of British subjects had variant alleles, consisting of TPMT*2 (n = 2), TPMT*3A (n = 17) and TPMT*3C (n = 1) alleles, The frequencies of mutant alleles in this study were 5.3 and 7.6% in British Caucasians and Ghanaians, respectively. Among Ghanaian tribes, Ewe subjects had a lower frequency of mutant alleles (5.9%) than Ga (13.2%) or Fanti (11.6%), although this did not reach statistical significance. This study provides the first analysis of TPMT mutant allele frequency in an African population and indicates that, unlike Caucasians, TPMT*3C is the most common allele in African subjects.
引用
收藏
页码:367 / 370
页数:4
相关论文
共 26 条
[1]  
CAVALLISFORZA LL, 1996, HIST GEOGRAPHY HUMAN, P11
[2]  
COLLIEDUGUID ESR, 1999, IN PRESS PHARMACOGEN
[3]  
de la Moureyre CSV, 1998, HUM MUTAT, V12, P177, DOI 10.1002/(SICI)1098-1004(1998)12:3<177::AID-HUMU5>3.0.CO
[4]  
2-E
[5]   ALTERED MERCAPTOPURINE METABOLISM, TOXIC EFFECTS, AND DOSAGE REQUIREMENT IN A THIOPURINE METHYLTRANSFERASE-DEFICIENT CHILD WITH ACUTE LYMPHOCYTIC-LEUKEMIA [J].
EVANS, WE ;
HORNER, M ;
CHU, YQ ;
KALWINSKY, D ;
ROBERTS, WM .
JOURNAL OF PEDIATRICS, 1991, 119 (06) :985-989
[6]   Polymorphism of the thiopurine S-methyltransferase gene in African-Americans [J].
Hon, YY ;
Fessing, MY ;
Pui, CH ;
Relling, MV ;
Krynetski, EY ;
Evans, WE .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :371-376
[7]   THIOPURINE METHYLTRANSFERASE ACTIVITY IN A SAMPLE-POPULATION OF BLACK SUBJECTS IN FLORIDA [J].
JONES, CD ;
SMART, C ;
TITUS, A ;
BLYDEN, G ;
DORVIL, M ;
NWADIKE, N .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (03) :348-353
[8]   INTERETHNIC DIFFERENCE IN THIOPURINE METHYLTRANSFERASE ACTIVITY [J].
KLEMETSDAL, B ;
TOLLEFSEN, E ;
LOENNECHEN, T ;
JOHNSEN, K ;
UTSI, E ;
GISHOLT, K ;
WIST, E ;
AARBAKKE, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) :24-31
[9]   Genetic polymorphism of thiopurine S-methyltransferase: Clinical importance and molecular mechanisms [J].
Krynetski, EY ;
Tai, HL ;
Yates, CR ;
Fessing, MY ;
Loennechen, T ;
Schuetz, JD ;
Relling, MV ;
Evans, WE .
PHARMACOGENETICS, 1996, 6 (04) :279-290
[10]   A SINGLE-POINT MUTATION LEADING TO LOSS OF CATALYTIC ACTIVITY IN HUMAN THIOPURINE S-METHYLTRANSFERASE [J].
KRYNETSKI, EY ;
SCHUETZ, JD ;
GALPIN, AJ ;
PUI, CH ;
RELLING, MV ;
EVANS, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) :949-953